Company Description
Option Care Health, Inc. offers home and alternate site infusion services in the United States.
The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer’s disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.
The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations.
Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
| Country | United States |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 8,088 |
| CEO | John Rademacher |
Contact Details
Address: 3000 Lakeside Drive, Suite 300N Bannockburn, Illinois 60015 United States | |
| Phone | 312 940 2443 |
| Website | optioncarehealth.com |
Stock Details
| Ticker Symbol | OPCH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001014739 |
| CUSIP Number | 68404L201 |
| ISIN Number | US68404L2016 |
| Employer ID | 05-0489664 |
| SIC Code | 8082 |
Key Executives
| Name | Position |
|---|---|
| John C. Rademacher | Chief Executive Officer, President and Director |
| Michael H. Shapiro | Executive Vice President and Chief Financial Officer |
| Luke Whitworth | Chief Operating Officer |
| Collin G. Smyser | General Counsel and Corporate Secretary |
| Christopher L. Grashoff | Chief Growth Officer |
| Nicole Maggio | Senior Vice President, Controller and Principal Accounting Officer |
| Brett Michalak | Chief Information Officer |
| Stacey Mahone | Senior Vice President and Chief Compliance Officer |
| Michael Bavaro | Chief Human Resources and Chief Diversity Officer |
| Julie Koenig | Senior Vice President of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 2, 2025 | ARS | Filing |
| Apr 2, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 2, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 19, 2025 | PRE 14A | Other preliminary proxy statements |
| Feb 28, 2025 | 144 | Filing |
| Feb 26, 2025 | 10-K | Annual Report |
| Feb 26, 2025 | 8-K | Current Report |
| Jan 13, 2025 | 8-K | Current Report |
| Dec 4, 2024 | SCHEDULE 13G/A | Filing |
| Nov 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |